Supportive care
Asymptomatic patients with no right to left shunting and minimal cardiomegaly may only require regular monitoring
Endocarditis prophylaxis
Avoidance of sport in moderate or severe disease (patients with mild disease may participate in sport)
Medical management
Diuretics for heart failure 
Digoxin 
Procainamide, flecainide, propafenone, amiodarone
Surgical repair
Recommended for: 
Limited exercise capacity (NYHA III - IV)
Increasing heart size (cardiothoracic ration > 0.65)
Significant cyanosis (resting SpO2 < 90%)
Severe symptomatic tricuspid regurgitation
Transient ischemic attack or stroke
Tricuspid repair maintaining the native tricuspid valve whenever possible
Catheter ablation for dysrhythmias 
Pacemaker insertion for persistent dysrhythmias 
Asymptomatic patients with no right to left shunting and minimal cardiomegaly may only require regular monitoring
Endocarditis prophylaxis
Avoidance of sport in moderate or severe disease (patients with mild disease may participate in sport)
Diuretics for heart failure 
Digoxin 
Procainamide, flecainide, propafenone, amiodarone
Recommended for: 
Limited exercise capacity (NYHA III - IV)
Increasing heart size (cardiothoracic ration > 0.65)
Significant cyanosis (resting SpO2 < 90%)
Severe symptomatic tricuspid regurgitation
Transient ischemic attack or stroke
Tricuspid repair maintaining the native tricuspid valve whenever possible
Catheter ablation for dysrhythmias 
Pacemaker insertion for persistent dysrhythmias 
Limited exercise capacity (NYHA III - IV)
Increasing heart size (cardiothoracic ration > 0.65)
Significant cyanosis (resting SpO2 < 90%)
Severe symptomatic tricuspid regurgitation
Transient ischemic attack or stroke
Ebstein anomaly
Other cyanotic congenital heart disease
Tricuspid atresia
THE MISFITS [12]
Tetralogy of Fallot
Trauma
Transposition of the great arteries
Heart